HHL-U:CA:TSX-Harvest Healthcare Leaders Income ETF (USD)

ETF | Others |

Last Closing

CAD 8.74

Change

-0.09 (-1.02)%

Market Cap

N/A

Volume

511.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-12 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

-0.29 (-1.07%)

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.02%)

CAD 5.38B
XEQT:CA iShares Core Equity Portfolio

+0.07 (+0.21%)

CAD 5.22B
PHYS-U:CA Sprott Physical Gold Trust

-0.13 (-0.65%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.11 (+0.29%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+0.44 (+0.96%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

-0.13 (-0.54%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

-0.07 (-0.68%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.14 (-0.62%)

CAD 2.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

CAD 2.68B

ETFs Containing HHL-U:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.94% 24% F 29% F
Dividend Return 4.83% 79% B- 70% C-
Total Return 7.77% 30% F 32% F
Trailing 12 Months  
Capital Gain 9.11% 32% F 35% F
Dividend Return 6.57% 81% B- 75% C
Total Return 15.69% 37% F 39% F
Trailing 5 Years  
Capital Gain 12.20% 44% F 49% F
Dividend Return 42.68% 94% A 93% A
Total Return 54.88% 66% D+ 64% D
Average Annual (5 Year Horizon)  
Capital Gain 3.47% 58% F 48% F
Dividend Return 3.87% 59% D- 44% F
Total Return 0.41% 88% B+ 28% F
Risk Return Profile  
Volatility (Standard Deviation) 7.28% 61% D- 81% B-
Risk Adjusted Return 53.21% 73% C 69% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike